Skip to content

Browse Protocols

Wrote one of these methods? Find yours by DOI and review the entry.

Find your method
934 protocols found
934 protocols found
BRAIN
Publication-derived

Schizophrenia Brain Organoids with Gene Editing (BN-DS-23)

Source Qu et al., 2023 · National University of Singapore, Yong Loo Lin School of Medicine · DOI

Duration: 120 days Cell source: Human ESC, Human iPSC Full SOP · 11 phases · QC included
Disease modelling
BN-DS-23 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver 2D Cell Cultures for Regenerative Medicine (LV-DS-13)

Source Takebe et al., 2013 · Yokohama City University · DOI

Duration: 60 days Cell source: Human iPSC Full SOP · 12 phases · QC included
Disease modelling
LV-DS-13 Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain Organoids for Disease and Development (2017) (BN-DS-17)

Source Lancaster et al., 2017 · IMBA—Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria · DOI

Duration: 60 days Cell source: Human ESC (H9, H1) and Human iPSC Full SOP · 3 phases · QC included
Disease modelling
BN-DS-17 Full SOP with Academic or a plan
BRAIN
Publication-derived

Neurodevelopmental Disorder Cerebral Organoids (BN-DS-20)

Source Qiao et al., 2020 · Department of Biomedical Engineering, Wuhan University School of Basic Medical Sciences · DOI

Duration: 72 days Cell source: Human iPSC Full SOP · 9 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Colorectal Cancer Colonic Organoids with Gene Editing (2015) (IN-CA-15)

Source Drost et al., 2015 · Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht · DOI

Duration: 56 days Cell source: Human iPSC-derived intestinal stem cells from duodenal biopsies and colon tissue Full SOP · 9 phases · QC included
Disease modelling
IN-CA-15 Full SOP with Academic or a plan
LIVER
Publication-derived

Fatty Liver Disease Organoids (2024, No. 2) (LV-DS-24)

Source Morell et al., 2024 · Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge · DOI

Duration: 51 days Cell source: Human iPSC Full SOP · 12 phases · QC included
Disease modelling
LV-DS-24 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Inflammatory Bowel Disease Intestinal Organoids for Developmental Studies (IN-DS-17)

Source Kraiczy et al., 2017 · DOI

Duration: 14 days Cell source: Patient-Derived iPSC (Pediatric and Foetal samples) Full SOP · 5 phases · QC included
Disease modelling
IN-DS-17 Full SOP with Academic or a plan
SKIN
Publication-derived

Systemic Sclerosis Skin Organoids (SK-DS-22)

Source Kim et al., 2022 · Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea · DOI

Duration: 30 days Cell source: Patient-Derived iPSC (Systemic Sclerosis) Full SOP · 9 phases · QC included
Drug screening
SK-DS-22 Full SOP with Academic or a plan
BRAIN
Publication-derived

Meningioma Brain Organoids (2025) (BN-CA-25)

Source Zohdy et al., 2025 · Emory University, Department of Neurosurgery · DOI

Duration: 80 days Cell source: Patient-Derived Meningioma Tissue Full SOP · 10 phases · QC included
Disease modelling
BN-CA-25 Full SOP with Academic or a plan
GASTRIC
Publication-derived

Rectal Adenocarcinoma Tumouroids (GS-DS-19)

Source Ganesh et al., 2019 · Memorial Sloan Kettering Cancer Center · DOI

Duration: 112 days Cell source: Patient-Derived Cancer Tissue (Rectal Adenocarcinoma) Full SOP · 9 phases · QC included
Drug screening
GS-DS-19 Full SOP with Academic or a plan
LIVER
Publication-derived

Alcohol-Related Liver Disease Organoids for Developmental Studies (LV-DS-19)

Source Wang et al., 2019 · Beijing Institute of Health Service and Transfusion Medicine · DOI

Duration: 36 days Cell source: Human ESC Full SOP · 7 phases · QC included
Disease modelling
LV-DS-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

Cryptococcal Meningitis Brain Organoids with Vasculature (BN-DS-25)

Source Bennett et al., 2025 · Department of Pharmacology, School of Medicine, University of California, Davis · DOI

Duration: 18 days Cell source: Human iPSC-derived brain microvascular endothelial cells (immortalized HCMEC/D3), primary human brain endothelial cells, primary human astrocytes, primary human brain vascular pericytes Full SOP · 7 phases · QC included
Disease modelling
BN-DS-25 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Intestinal Organoids for Developmental Studies (2011, No. 2) (IN-TX-11)

Source Sato et al., 2011 · Hubrecht Institute, KNAW and University Medical Center Utrecht · DOI

Duration: 14 days Cell source: Mouse intestinal crypt Lgr5+ stem cells and CD24+ Paneth cells Full SOP · 6 phases · QC included
Developmental biology
IN-TX-11 Full SOP with Academic or a plan
CARDIAC
Publication-derived

Cardiac Embryo Models for Disease Modelling (CD-DS-23)

Source Abdyev et al., 2023 · Koltsov Institute of Developmental Biology of Russian Academy of Sciences, Moscow · DOI

Duration: 110 days Cell source: Human iPSC Full SOP · 9 phases · QC included
Disease modelling
CD-DS-23 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Intestinal Organoids for Disease Modelling (No. 2)

Duration: 14 days Cell source: Human intestinal crypts / Mouse intestinal crypts Full SOP · 5 phases · QC included
Disease modelling
Full SOP with Academic or a plan
BRAIN
Publication-derived

Cortical Organoids for Regenerative Medicine (BN-DS-23)

Source Jgamadze et al., 2023 · Perelman School of Medicine, University of Pennsylvania · DOI

Duration: 88 days Cell source: Human iPSC (C1.2, AICS); Human ESC (H9) Full SOP · 7 phases · QC included
Disease modelling
BN-DS-23 Full SOP with Academic or a plan
LUNG
Publication-derived

Non-Small Cell Lung Cancer Airway Organoids (AW-CA-19)

Source Sachs et al., 2019 · Oncode Institute, Hubrecht Institute-KNAW and UMC Utrecht, Utrecht, The Netherlands · DOI

Duration: 21 days Cell source: Human adult lung epithelial cells (from broncho-alveolar lavage or resection tissue); Patient-derived iPSC (Cystic Fibrosis); Patient-derived lung cancer cells (NSCLC) Full SOP · 8 phases · QC included
Drug screening
AW-CA-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

Familial Alzheimer's Disease Cerebral Organoids with Gene Editing

Source Yin et al. · Program in Neuroscience and Behavioural Disorders, Duke-NUS Medical School, Singapore · DOI

Duration: 63 days Cell source: Patient-Derived iPSC (Familial Alzheimer's Disease, PSEN2[N141I] mutation) Full SOP · 12 phases · QC included
Disease modelling
Full SOP with Academic or a plan
LIVER
Publication-derived

Drug-Induced Liver Fibrosis Organoids (LV-DI-16)

Source Leite et al., 2016 · Liver Cell Biology Laboratory, Vrije Universiteit Brussel (VUB), Belgium · DOI

Duration: 21 days Cell source: Differentiated HepaRG cells (Human hepatocyte-like) and Primary Human Hepatic Stellate Cells (HSCs) Full SOP · 5 phases · QC included
Drug screening
LV-DI-16 Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain Ischaemia Cortical Organoids (BN-DS-23)

Source De Paola et al., 2023 · Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy · DOI

Duration: 72 days Cell source: Human iPSC Full SOP · 11 phases · QC included
Disease modelling
BN-DS-23 Full SOP with Academic or a plan
BRAIN
Publication-derived

Parkinson's Disease Brain Organoids (BN-DS-20)

Source Ha et al., 2020 · Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, South Korea · DOI

Duration: 30 days Cell source: Human iPSC; Patient-Derived iPSC (Parkinson's disease, LRRK2 G2019S) Full SOP · 8 phases · QC included
Drug screening
BN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Lower-Grade Glioma Brain Tumouroids (BN-DS-22)

Source Abdullah et al., 2022 · University of Texas Southwestern Medical Center · DOI

Duration: 28 days Cell source: Patient-Derived Glioma Tissue (Primary resection samples) Full SOP · 4 phases · QC included
Drug screening
BN-DS-22 Full SOP with Academic or a plan
BRAIN
Publication-derived

Parkinson's Disease Midbrain Organoids for Drug Screening (2020) (BN-NT-20)

Source Monzel et al., 2020 · Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg · DOI

Duration: 48 days Cell source: Human iPSC Full SOP · 11 phases · QC included
Drug screening
BN-NT-20 Full SOP with Academic or a plan
LIVER
Publication-derived

Fatty Liver Disease Bioprinted and Engineered Tissues (LV-DS-25)

Source Liu et al., 2025 · Stanford University · DOI

Duration: 19 days Cell source: Human iPSC-derived hepatic organoids Full SOP · 8 phases · QC included
Disease modelling
LV-DS-25 Full SOP with Academic or a plan